NCT07560696 Feasibility of Web-based Therapy Sessions
| NCT ID | NCT07560696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Liverpool University Hospitals NHS Foundation Trust |
| Condition | Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-07-03 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-07-03 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility study is to explore rehabilitation outcomes, usability and user experience of a web-based platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders in critical illness and stroke disorders. The main question it aims to answer is: " Is it feasible to use a web-based platform for delivering rehabilitation treatment in a large acute National Health Care Organisation" Participants will undergo therapy sessions prescribed by therapists on a web-based platform instead of the conventional paper-based therapy sessions for their cognitive and speech rehabilitation needs.
Eligibility Criteria
Inclusion Criteria: * Patients with cognitive impairment and/or speech impairment being treated at the LUHFT Intensive Care Units and the Stroke wards * Need for Cognitive and/or speech and Language rehabilitation Exclusion Criteria: * Inability to obtain consent * Refusal to take part in the study * Failure to engage with the Cognishine platform * Inability to operate a mobile device/ tablet with support * Unavailability of study therapist to provide training of patients * Unstable medical condition
Contact & Investigator
Matthew Noonan
STUDY CHAIR
Liverpool University Hospitals NHS Foundation Trust
Frequently Asked Questions
Who can join the NCT07560696 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07560696 currently recruiting?
Yes, NCT07560696 is actively recruiting participants. Contact the research team at Vinoth.Sankar@liverpoolft.nhs.uk for enrollment information.
Where is the NCT07560696 trial being conducted?
This trial is being conducted at Liverpool, United Kingdom.
Who is sponsoring the NCT07560696 clinical trial?
NCT07560696 is sponsored by Liverpool University Hospitals NHS Foundation Trust. The principal investigator is Matthew Noonan at Liverpool University Hospitals NHS Foundation Trust. The trial plans to enroll 80 participants.